Search research articles
Contact Us
Filters
Showing results (31-40 of 101) with videos related to
Page
of 11
Sort By:
Cancer Cell
|
June 24, 2022
Sex and cancer immunotherapy: Current understanding and challenges
Laura Pala, Tommaso De Pas, Chiara Catania, et al.
Cancer Investigation
|
October 30, 2020
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature
Laura Pala, Fabio Conforti, Emilia Cocorocchio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2022
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy
Chiara Corti, Fabio Conforti, Laura Pala, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2019
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial
Fabio Conforti, Laura Pala, Eleonora Pagan, et al.
Therapeutic Advances in Medical Oncology
|
December 4, 2020
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers
Maristella Saponara, Laura Pala, Fabio Conforti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2026
"Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?"
Fabio Conforti, Isabella Sala, Laura Pala, et al.
Critical Reviews in Oncology/Hematology
|
October 26, 2013
Targeting ALK in patients with advanced non small cell lung cancer: biology, diagnostic and therapeutic options
Chiara Lazzari, Gianluca Spitaleri, Chiara Catania, et al.
Current Oncology (Toronto, Ont.)
|
March 28, 2023
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review
Nunzio Digiacomo, Tommaso De Pas, Giovanna Rossi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 2, 2013
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung
Fabio Conforti, Chiara Catania, Francesca Toffalorio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 23, 2015
Erlotinib efficacy in NSCLC patients with high polysomy of chromosome 7 and EGFR/KRas wild-type tumors
Francesca Toffalorio, Filippo de Marinis, Fabio Conforti, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 101) with videos related to
Sort By:
Page
of 11
Cancer Cell
|
June 24, 2022
Sex and cancer immunotherapy: Current understanding and challenges
Laura Pala, Tommaso De Pas, Chiara Catania, et al.
Cancer Investigation
|
October 30, 2020
Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature
Laura Pala, Fabio Conforti, Emilia Cocorocchio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 12, 2022
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy
Chiara Corti, Fabio Conforti, Laura Pala, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 17, 2019
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial
Fabio Conforti, Laura Pala, Eleonora Pagan, et al.
Therapeutic Advances in Medical Oncology
|
December 4, 2020
Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers
Maristella Saponara, Laura Pala, Fabio Conforti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2026
"Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?"
Fabio Conforti, Isabella Sala, Laura Pala, et al.
Critical Reviews in Oncology/Hematology
|
October 26, 2013
Targeting ALK in patients with advanced non small cell lung cancer: biology, diagnostic and therapeutic options
Chiara Lazzari, Gianluca Spitaleri, Chiara Catania, et al.
Current Oncology (Toronto, Ont.)
|
March 28, 2023
Exon-18-EGFR Mutated Transformed Small-Cell Lung Cancer: A Case Report and Literature Review
Nunzio Digiacomo, Tommaso De Pas, Giovanna Rossi, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 2, 2013
EGFR tyrosine kinase inhibitors beyond focal progression obtain a prolonged disease control in patients with advanced adenocarcinoma of the lung
Fabio Conforti, Chiara Catania, Francesca Toffalorio, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 23, 2015
Erlotinib efficacy in NSCLC patients with high polysomy of chromosome 7 and EGFR/KRas wild-type tumors
Francesca Toffalorio, Filippo de Marinis, Fabio Conforti, et al.
Page
of 11